#cancer

There are no hard-and-fast rules, but here’s some guidance about when it may make more sense to choose one or the other.

Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.

Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.

Safety tips for the evolving pandemic. Plus: Which groups—such as those with cancer or HIV—are at higher risk for COVID-19 complications?

The ruling centered on PrEP as HIV prevention but could apply to cancer screenings and other services and drugs.

Plus: Study shows that cutting down on alcohol consumption can reduce cancer risk.

Three quarters of those who opted for medical aid to end their lives were people with cancer.

A study found that only 43% of clinical trials reported race and ethnicity. The FDA issued guidance to address these inequalities.

Novel therapies, improved technologies and a better understanding of the immune system could yield broad dividends.

Immunocompromised people ages 12 and older are also eligible for an additional shot.

Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.

The CDC’s move triggered mixed feelings from the public and laid bare a split within the health care community.

Transplant recipients, people with advanced HIV and certain people with cancer or autoimmune diseases can get an additional vaccine dose.

Boosters reduced the risk of hospitalization and death by about 80% for people with HIV, cancer, autoimmune conditions or organ transplants.

Yes! The Mark Cuban Cost Plus Drug Company sells cheaper generic drugs for diabetes, cancer, high blood pressure, HIV, hepatitis and more.

Boosters further reduce the risk of severe illness and can help curb coronavirus transmission.